000 | 01198 a2200313 4500 | ||
---|---|---|---|
005 | 20250514234934.0 | ||
264 | 0 | _c20050919 | |
008 | 200509s 0 0 eng d | ||
022 | _a0315-162X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKotter, Ina | |
245 | 0 | 0 |
_aInterferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN. _h[electronic resource] |
260 |
_bThe Journal of rheumatology _cAug 2005 |
||
300 |
_a1633; author reply 1634 p. _bdigital |
||
500 | _aPublication Type: Comment; Comparative Study; Letter | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBehcet Syndrome _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
650 | 0 | 4 | _aInfliximab |
650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
650 | 0 | 4 |
_aUveitis _xdrug therapy |
700 | 1 | _aDeuter, Cristoph | |
700 | 1 | _aStubiger, Nicole | |
700 | 1 | _aZierhut, Manfred | |
773 | 0 |
_tThe Journal of rheumatology _gvol. 32 _gno. 8 _gp. 1633; author reply 1634 |
|
999 |
_c15717175 _d15717175 |